Add to my selection

ORLADEYO (dichlorhydrate de bérotralstat)

Medicine - Posted on Dec 08 2021

Active substance (DCI)

dichlorhydrate de bérotralstat

history (2)

11/3/21

ORLADEYO 150 mg (berotralstat)

Key points Favourable opinion for reimbursement only as a second-line treatment for routine prevention of recurrent attacks ...

CAV :
54321

icône flèche

Technical information

ATC code

B06AC

Manufacturer

BIOCRYST (INTSEL CHIMOS)

Presentation

ORLADEYO 150 mg, gélule
Boîte de 28 gélules - (Code CIP : 34009 302 273 8 1)

All our publications

Congenital, genetic and rare diseases

Skin and connective tissue diseases